The synergy of autophagy inhibition and a PD-L1 blockade via an acid-sensitive nanoparticle (P-PDL1-CP) may also enhance the efficacy of prostate cancer immunotherapy [22]. The gene discussed is CD274; the disease is Familial prostate cancer.